Read More Healthcare Industry News Thermo Fisher raises $2.5bn in bonds—But what’s the bigger play behind the debt move? Thermo Fisher Scientific priced $2.5B in senior notes to fuel acquisitions, refinancing, and growth. See how the deal shapes TMO’s 2026 outlook. byPallavi MadhirajuOctober 1, 2025